Swiss National Bank Has $64.92 Million Stock Position in Cameco Co. (NYSE:CCJ)

Swiss National Bank lessened its holdings in shares of Cameco Co. (NYSE:CCJ) (TSE:CCO) by 3.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,263,300 shares of the basic materials company’s stock after selling 51,100 shares during the quarter. Swiss National Bank’s holdings in Cameco were worth $64,924,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. AGF Management Ltd. raised its stake in Cameco by 54.2% in the 4th quarter. AGF Management Ltd. now owns 3,393,233 shares of the basic materials company’s stock valued at $174,433,000 after acquiring an additional 1,193,266 shares during the period. Segra Capital Management LLC bought a new position in shares of Cameco in the third quarter valued at about $53,013,000. Fred Alger Management LLC lifted its stake in shares of Cameco by 99.7% during the 3rd quarter. Fred Alger Management LLC now owns 1,680,259 shares of the basic materials company’s stock worth $80,249,000 after buying an additional 839,077 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Cameco during the 4th quarter worth about $34,440,000. Finally, Massachusetts Financial Services Co. MA raised its holdings in Cameco by 44.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,151,105 shares of the basic materials company’s stock valued at $102,737,000 after acquiring an additional 664,828 shares during the period. Institutional investors own 70.21% of the company’s stock.

Cameco Trading Up 1.5 %

Shares of Cameco stock opened at $42.44 on Friday. The company has a quick ratio of 1.26, a current ratio of 2.88 and a debt-to-equity ratio of 0.20. Cameco Co. has a 12-month low of $35.43 and a 12-month high of $62.55. The company has a market capitalization of $18.47 billion, a price-to-earnings ratio of 151.55 and a beta of 1.04. The firm’s 50-day moving average price is $47.80 and its two-hundred day moving average price is $49.96.

Cameco (NYSE:CCJ) (TSE:CCO) last posted its quarterly earnings results on Thursday, February 20th. The basic materials company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Cameco had a net margin of 5.39% and a return on equity of 4.34%. The business had revenue of $845.54 million for the quarter, compared to analyst estimates of $1.09 billion. On average, analysts forecast that Cameco Co. will post 1.27 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CCJ shares. StockNews.com cut Cameco from a “hold” rating to a “sell” rating in a report on Tuesday, March 11th. Glj Research upped their price objective on Cameco from $62.76 to $75.68 and gave the company a “buy” rating in a report on Wednesday. Stifel Canada raised Cameco to a “strong-buy” rating in a report on Wednesday. Stifel Nicolaus initiated coverage on shares of Cameco in a research note on Wednesday. They issued a “buy” rating on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $90.00 price objective on shares of Cameco in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, seven have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $73.64.

About Cameco

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.